drugset / Trial / NCT00962429
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to examine if alpha lipoic acid is an effective treatment for chronic inflammatory demyelinating polyneuropathy (CIDP).
Timeline
- Start
- 2009-02
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | alpha-lipoic acid | Small molecule | 1200 mg | — |